—

Amgen Inc (AMGN) — Technical state

As of 2026-11-09 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 54 out of 100 (momentum 88 · quality 84 · valuation 34), as of 2026-11-11.
  • Signal: Trending — Above its 20-, 50- and 200-day — still in an uptrend. (as of 2026-11-09)
  • Trend: Amgen Inc trades 10.0% above its 50-day and 23.0% above its 200-day moving average. (as of 2026-11-09)
  • Index seat: HALO Growth 100

Amgen discovers, develops and manufactures human therapeutics, with products spanning rheumatoid arthritis, osteoporosis, cardiovascular risk reduction and rare diseases such as Enbrel, Prolia and Repatha. It sells through pharmaceutical wholesale distributors to hospitals, clinics and pharmacies worldwide.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the AMGN overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Trending

Above its 20-, 50- and 200-day — still in an uptrend.

The moving-average stack

FAQ · from the current data · as of 2026-11-09

Quick answers

What is the current Closelooknet signal on AMGN?

Trending — Above its 20-, 50- and 200-day — still in an uptrend. As of 2026-11-09; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is AMGN above its 50-day and 200-day moving averages?

As of 2026-11-09, Amgen Inc trades +10% above its 50-day and +23% above its 200-day average, with the 20-day +3.9% away.

How far is AMGN from its 52-week high?

3.9% below the 52-week high and 63.8% above the 52-week low, as of 2026-11-09.

Mentioned on Closelooknet

Where AMGN appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

Related in the Closelooknet universe

same Closelooknet index seat first, then Drug Manufacturers - General. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.